Viewing Study NCT01372956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-05-18 @ 10:25 AM
Study NCT ID: NCT01372956
Status: COMPLETED
Last Update Posted: 2011-12-22
First Post: 2011-06-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dyslipidemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LDL-C, cholesterol, risk factor View